دورية أكاديمية

Merosin-deficient congenital muscular dystrophy type 1a: detection of LAMA2 variants in Vietnamese patients.

التفاصيل البيبلوغرافية
العنوان: Merosin-deficient congenital muscular dystrophy type 1a: detection of LAMA2 variants in Vietnamese patients.
المؤلفون: Tran VK; Center for Gene and Protein Research, Hanoi Medical University, Hanoi, Vietnam., Nguyen NL; Institute of Genome Research, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam., Tran LNT; Center for Gene and Protein Research, Hanoi Medical University, Hanoi, Vietnam., Le PT; Center for Gene and Protein Research, Hanoi Medical University, Hanoi, Vietnam., Tran AH; Center for Gene and Protein Research, Hanoi Medical University, Hanoi, Vietnam., Pham TLA; Center for Gene and Protein Research, Hanoi Medical University, Hanoi, Vietnam., Lien NTK; Institute of Genome Research, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam., Xuan NT; Institute of Genome Research, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam., Thanh LT; Institute of Genome Research, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam., Ta TV; Center for Gene and Protein Research, Hanoi Medical University, Hanoi, Vietnam.; Hanoi Medical University Hospital, Hanoi Medical University, Hanoi, Vietnam., Tran TH; Center for Gene and Protein Research, Hanoi Medical University, Hanoi, Vietnam.; Hanoi Medical University Hospital, Hanoi Medical University, Hanoi, Vietnam., Nguyen HH; Institute of Genome Research, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.; Graduate University of Science and Technology, Vietnam Academy of Science and Technology (VAST), Hanoi, Vietnam.
المصدر: Frontiers in genetics [Front Genet] 2023 Jun 14; Vol. 14, pp. 1183663. Date of Electronic Publication: 2023 Jun 14 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101560621 Publication Model: eCollection Cited Medium: Print ISSN: 1664-8021 (Print) Linking ISSN: 16648021 NLM ISO Abbreviation: Front Genet Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Lausanne : Frontiers Research Foundation.
مستخلص: Background: Merosin-deficient congenital muscular dystrophy type 1A (MDC1A), also known as laminin-α2 chain-deficient congenital muscular dystrophy ( LAMA2 -MD), is an autosomal recessive disease caused by biallelic variants in the LAMA2 gene. In MDC1A, laminin- α2 chain expression is absent or significantly reduced, leading to some early-onset clinical symptoms including severe hypotonia, muscle weakness, skeletal deformity, non-ambulation, and respiratory insufficiency. Methods: Six patients from five unrelated Vietnamese families presenting with congenital muscular dystrophy were investigated. Targeted sequencing was performed in the five probands. Sanger sequencing was carried out in their families. Multiplex ligation-dependent probe amplification was performed in one family to examine an exon deletion. Results: Seven variants of the LAMA2 (NM_000426) gene were identified and classified as pathogenic/likely pathogenic variants using American College of Medical Genetics and Genomics criteria. Two of these variants were not reported in the literature, including c.7156-5_7157delinsT and c.8974_8975insTGAT. Sanger sequencing indicated their parents as carriers. The mothers of family 4 and family 5 were pregnant and a prenatal testing was performed. The results showed that the fetus of the family 4 only carries c.4717 + 5G>A in the heterozygous form, while the fetus of the family 5 carries compound heterozygous variants, including a deletion of exon 3 and c.4644C>A. Conclusion: Our findings not only identified the underlying genetic etiology for the patients, but also provided genetic counseling for the parents whenever they have an offspring.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2023 Tran, Nguyen, Tran, Le, Tran, Pham, Lien, Xuan, Thanh, Ta, Tran and Nguyen.)
References: Front Mol Neurosci. 2020 Feb 11;13:1. (PMID: 32116540)
Nature. 2019 Aug;572(7767):125-130. (PMID: 31341277)
Biomed Rep. 2020 Feb;12(2):46-50. (PMID: 31929873)
Ann Neurol. 2016 Jul;80(1):101-11. (PMID: 27159402)
Curr Top Membr. 2015;76:31-60. (PMID: 26610911)
J Neuromuscul Dis. 2014;1(2):169-179. (PMID: 27858771)
Ann Neurol. 2009 Jan;65(1):47-56. (PMID: 19086074)
Gene Ther. 2023 Apr;30(3-4):323-335. (PMID: 36089633)
Nucleic Acids Res. 2021 Jul 2;49(W1):W446-W451. (PMID: 33893808)
Antioxidants (Basel). 2020 Mar 18;9(3):. (PMID: 32197453)
Neurology. 1998 Jul;51(1):101-10. (PMID: 9674786)
Front Mol Neurosci. 2020 Aug 05;13:123. (PMID: 32848593)
Nat Genet. 1995 Oct;11(2):216-8. (PMID: 7550355)
Hum Mutat. 2018 Oct;39(10):1314-1337. (PMID: 30055037)
Arch Dis Child. 1999 Jun;80(6):542-7. (PMID: 10332004)
J Genet Couns. 2016 Dec;25(6):1146-1156. (PMID: 27422780)
Hum Genet. 1996 Mar;97(3):277-9. (PMID: 8786062)
J Pharmacol Exp Ther. 2009 Dec;331(3):787-95. (PMID: 19759319)
Am J Pathol. 2014 May;184(5):1518-28. (PMID: 24631023)
Neuromuscul Disord. 2020 Jun;30(6):457-471. (PMID: 32444167)
Eur J Hum Genet. 2002 Feb;10(2):91-4. (PMID: 11938437)
Diagnostics (Basel). 2020 Sep 24;10(10):. (PMID: 32987775)
Clin Genet. 2015 Mar;87(3):233-43. (PMID: 24611677)
Genet Med. 2015 May;17(5):405-24. (PMID: 25741868)
J Bone Miner Res. 2022 Feb;37(2):202-214. (PMID: 34633109)
Appl Clin Genet. 2019 Jul 03;12:113-130. (PMID: 31308722)
Neuromuscul Disord. 2010 Apr;20(4):241-50. (PMID: 20207543)
Neuromuscul Disord. 2004 Jan;14(1):56-69. (PMID: 14659414)
Cell. 1995 Mar 10;80(5):675-9. (PMID: 7889563)
Genet Med. 2020 Sep;22(9):1478-1488. (PMID: 32528171)
Fetal Pediatr Pathol. 2018 Dec;37(6):418-423. (PMID: 30358464)
J Med Genet. 1998 Mar;35(3):211-7. (PMID: 9541105)
Neuromuscul Disord. 2021 Oct;31(10):931-942. (PMID: 34470717)
Dis Model Mech. 2023 Jun 1;16(6):. (PMID: 37021539)
Orphanet J Rare Dis. 2021 Jul 19;16(1):319. (PMID: 34281576)
Neuromuscul Disord. 2019 May;29(5):376-380. (PMID: 31040037)
Ann Neurol. 2012 May;71(5):699-708. (PMID: 22522482)
Hum Mutat. 2003 Feb;21(2):103-11. (PMID: 12552556)
Mol Genet Genomic Med. 2020 Nov;8(11):e1387. (PMID: 32936536)
Front Mol Neurosci. 2020 Apr 23;13:60. (PMID: 32390798)
Clin Genet. 2008 Dec;74(6):502-12. (PMID: 18700894)
Clin Genet. 2019 Sep;96(3):207-215. (PMID: 31066047)
BMC Med Genomics. 2021 Apr 21;14(1):113. (PMID: 33882917)
Pediatr Neurol. 2002 Jan;26(1):30-6. (PMID: 11814732)
Neuromuscul Disord. 2005 Oct;15(9-10):588-94. (PMID: 16084089)
Sci Rep. 2018 Nov 2;8(1):16302. (PMID: 30389963)
Ann Clin Transl Neurol. 2020 Oct;7(10):1870-1882. (PMID: 32910545)
Genome Med. 2021 Feb 22;13(1):31. (PMID: 33618777)
Nat Med. 2017 Aug;23(8):984-989. (PMID: 28714989)
Cell Adh Migr. 2013 Jan-Feb;7(1):111-21. (PMID: 23154401)
J Med Genet. 2001 Oct;38(10):649-57. (PMID: 11584042)
فهرسة مساهمة: Keywords: LAMA2 gene; MDC1A; Vietnamese; congenital muscular dystrophy; merosin-deficient congenital muscular dystrophy type 1A
تواريخ الأحداث: Date Created: 20230630 Latest Revision: 20230703
رمز التحديث: 20230703
مُعرف محوري في PubMed: PMC10301838
DOI: 10.3389/fgene.2023.1183663
PMID: 37388928
قاعدة البيانات: MEDLINE
الوصف
تدمد:1664-8021
DOI:10.3389/fgene.2023.1183663